SCHEMBL7593290

SCHEMBL7593290

COc1ccc(Cn2c(=O)[nH]c3ccccc3c2=O)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.77
KMT2A Q03164 5/20 0.77
ALDH1A1 P00352 4/20 0.74
KDM4E B2RXH2 3/20 0.74
SMN1; SMN2 Q16637 3/20 0.74
HPGD P15428 2/20 0.74
LMNA P02545 3/20 0.59
MAPK10 P53779 2/20 0.59
GAA P10253 2/20 0.59
USP2 O75604 1/20 0.59
PKM P14618 1/20 0.59
TSHR P16473 1/20 0.59
CASP1 P29466 1/20 0.59
HTT P42858 1/20 0.59
CASP7 P55210 1/20 0.59
NPSR1 Q6W5P4 1/20 0.59
HSD17B10 Q99714 1/20 0.59
CYP1A2 P05177 1/20 0.58
TDP1 Q9NUW8 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30877025 0.85 HPGD (1.00) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL6982894 0.85 HPGD (1.00) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL19291210 0.85 HPGD (0.80) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL7648334 0.83 KDM4E (0.72) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL7655012 0.83 KDM4E (0.72) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL7649819 0.83 KDM4E (0.72) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL7745468 0.82 LMNA (0.70) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL17242598 0.82 KDM4E (0.70) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL19577097 0.81 HSD17B10 (0.62) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL17242517 0.81 KDM4E (0.76) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1207886-B1 SPHINGOMYELINASE INHIBITORS AS AGENTS WITH ANTIAPOPTOTIC AND ANTISEPTIC ACTION BIOFRONTERA PHARMACEUTICALS GM (DE) 2005-11-16 EP disclosed
US-6407116-B1 2,4-DIOXO-1,2,3,4-TETRAHYDROQUINAZOLINE DERIVATIVES; ANTIALLERGENS, ANTIASTHMATICS, ANTIHISTAMINES, AND ANTIINFLAMMATORY AGENTS TAKEDA CHEMICAL INDUSTRIES, INC. (JP) 2002-06-18 US disclosed
EP-1207886-A2 SPHINGOMYELINASE INHIBITORS AS AGENTS WITH ANTIAPOPTOTIC AND ANTISEPTIC ACTION Biofrontera Pharmaceuticals GmbH (DE) 2002-05-29 EP disclosed
WO-2000072833-A2 PHARMACEUTICAL PREPARATIONS FOR INHIBITING SPHINGOMYELINASE Universität Heidelberg (DE) 2000-12-07 WO disclosed
EP-1026160-A1 NITROGENOUS FUSED-RING COMPOUNDS, PROCESS FOR THE PREPARATION OF THE SAME, AND DRUGS Takeda Chemical Industries, Ltd. (JP) 2000-08-09 EP disclosed